Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Iron, Hepcidin, and Death in Human AKI.

Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, Eisenga MF, Singh K, Babitt JL, Kellum JA, Palevsky PM, Christov M, Waikar SS.

J Am Soc Nephrol. 2019 Feb 8. pii: ASN.2018100979. doi: 10.1681/ASN.2018100979. [Epub ahead of print]

PMID:
30737269
2.

Fibroblast Growth Factor 23 and Klotho in AKI.

Christov M, Neyra JA, Gupta S, Leaf DE.

Semin Nephrol. 2019 Jan;39(1):57-75. doi: 10.1016/j.semnephrol.2018.10.005. Review.

PMID:
30606408
3.

Dysregulated Mineral Metabolism in AKI.

Leaf DE, Christov M.

Semin Nephrol. 2019 Jan;39(1):41-56. doi: 10.1016/j.semnephrol.2018.10.004. Review.

PMID:
30606407
4.

Phosphate homeostasis disorders.

Christov M, Jüppner H.

Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):685-706. doi: 10.1016/j.beem.2018.06.004. Epub 2018 Jun 18. Review.

PMID:
30449549
5.

Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities.

Christov M, Clark AR, Corbin B, Hakroush S, Rhee EP, Saito H, Brooks D, Hesse E, Bouxsein M, Galjart N, Jung JY, Mundel P, Jüppner H, Weins A, Greka A.

JCI Insight. 2018 Feb 22;3(4). pii: 95091. doi: 10.1172/jci.insight.95091. [Epub ahead of print]

6.

Acute blood loss stimulates fibroblast growth factor 23 production.

Rabadi S, Udo I, Leaf DE, Waikar SS, Christov M.

Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F132-F139. doi: 10.1152/ajprenal.00081.2017. Epub 2017 Sep 6.

7.

Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels.

Knab VM, Corbin B, Andrukhova O, Hum JM, Ni P, Rabadi S, Maeda A, White KE, Erben RG, Jüppner H, Christov M.

Endocrinology. 2017 May 1;158(5):1130-1139. doi: 10.1210/en.2016-1451.

8.

Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.

Leaf DE, Jacob KA, Srivastava A, Chen ME, Christov M, Jüppner H, Sabbisetti VS, Martin A, Wolf M, Waikar SS.

J Am Soc Nephrol. 2017 Jun;28(6):1877-1885. doi: 10.1681/ASN.2016080836. Epub 2016 Dec 27.

9.

Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts.

Menn-Josephy H, Lee CS, Nolin A, Christov M, Rybin DV, Weinberg JM, Henderson J, Bonegio R, Havasi A.

Am J Nephrol. 2016;44(4):289-299. Epub 2016 Sep 15.

10.
11.

Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.

Leaf DE, Christov M, Jüppner H, Siew E, Ikizler TA, Bian A, Chen G, Sabbisetti VS, Bonventre JV, Cai X, Wolf M, Waikar SS.

Kidney Int. 2016 Apr;89(4):939-48. doi: 10.1016/j.kint.2015.12.035. Epub 2016 Feb 17.

12.

TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib).

Molinaro A, Tiosano D, Takatani R, Chrysis D, Russell W, Koscielniak N, Kottler ML, Agretti P, De Marco G, Ahtiainen P, Christov M, Mäkitie O, Tonacchera M, Jüppner H.

J Bone Miner Res. 2015 May;30(5):906-12. doi: 10.1002/jbmr.2408.

13.

Fibroblast growth factor 23 in acute kidney injury.

Christov M.

Curr Opin Nephrol Hypertens. 2014 Jul;23(4):340-5. doi: 10.1097/01.mnh.0000447021.51722.2f. Review.

14.

The effect of aging on EEG brain oscillations related to sensory and sensorimotor functions.

Dushanova J, Christov M.

Adv Med Sci. 2014 Mar;59(1):61-7. doi: 10.1016/j.advms.2013.08.002. Epub 2014 Mar 19.

PMID:
24797977
15.

Dietary phosphate: the challenges of exploring its role in FGF23 regulation.

Christov M, Jüppner H.

Kidney Int. 2013 Oct;84(4):639-41. doi: 10.1038/ki.2013.198.

16.

Auditory event-related brain potentials for an early discrimination between normal and pathological brain aging.

Dushanova J, Christov M.

Neural Regen Res. 2013 May 25;8(15):1390-9. doi: 10.3969/j.issn.1673-5374.2013.15.006.

17.

Plasma FGF23 levels increase rapidly after acute kidney injury.

Christov M, Waikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D, Pajevic PD, Wolf M, Jüppner H.

Kidney Int. 2013 Oct;84(4):776-85. doi: 10.1038/ki.2013.150. Epub 2013 May 8.

18.

Insights from genetic disorders of phosphate homeostasis.

Christov M, Jüppner H.

Semin Nephrol. 2013 Mar;33(2):143-57. doi: 10.1016/j.semnephrol.2012.12.015. Review.

19.

Bone biopsy in renal osteodystrophy: continued insights into a complex disease.

Christov M, Pereira R, Wesseling-Perry K.

Curr Opin Nephrol Hypertens. 2013 Mar;22(2):210-5. doi: 10.1097/MNH.0b013e32835dda01. Review.

PMID:
23318700
20.

FGF-23 levels in patients with AKI and risk of adverse outcomes.

Leaf DE, Wolf M, Waikar SS, Chase H, Christov M, Cremers S, Stern L.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1217-23. doi: 10.2215/CJN.00550112. Epub 2012 Jun 14.

21.

Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis.

Christov M, Koren S, Yuan Q, Baron R, Lanske B.

Endocrinology. 2011 May;152(5):2031-6. doi: 10.1210/en.2010-1351. Epub 2011 Mar 22.

22.

Tubular transport: core curriculum 2010.

Christov M, Alper SL.

Am J Kidney Dis. 2010 Dec;56(6):1202-17. doi: 10.1053/j.ajkd.2010.09.011. Epub 2010 Oct 30. Review. No abstract available.

23.

Molecular analysis of a new cytoplasmic male sterile genotype in sunflower.

Spassova M, Christov M, Bohorova N, Petrov P, Dudov K, Atanassov A, Nijkamp HJ, Hille J.

FEBS Lett. 1992 Feb 3;297(1-2):159-63.

24.

[Water-soluble oleandomycinlactobionate].

Christov M.

Pharmazie. 1972 May;27(5):339-40. German. No abstract available.

PMID:
4647564

Supplemental Content

Loading ...
Support Center